Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Nov;14(5):656–658. doi: 10.1128/aac.14.5.656

Synergistic Activity of Gentamicin with Trimethoprim or Sulfamethoxazole-Trimethoprim Against Escherichia coli and Klebsiella pneumoniae

J W Paisley 1, J A Washington II 1
PMCID: PMC352530  PMID: 365085

Abstract

The effect of combinations of gentamicin with trimethoprim or sulfamethoxazole-trimethoprim against clinical isolates of Escherichia coli (11 strains) and Klebsiella pneumoniae (12 strains) was examined by using a microdilution checkerboard technique. All isolates were susceptible to each antimicrobial agent. Synergism, defined as at least a 2-log2-dilution lowering of the minimal inhibitory concentration of either antibiotic in the combination compared with the minimal inhibitory concentration of the antibiotic alone, was observed with 15 of 23 (65%) isolates tested against trimethoprim and gentamicin and 14 of 23 (61%) isolates tested against sulfamethoxazole-trimethoprim and gentamicin. A 3-log2-dilution lowering of the minimal inhibitory concentration of either antibiotic was observed in 7 of 23 (30%) trimethoprim and gentamicin trials and 3 of 23 (13%) sulfamethoxazole-trimethoprim and gentamicin trials. Antagonism was observed in 3 of 46 combination trials and only with strains of K. pneumoniae.

Full text

PDF
656

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cluzel R., Sirot J., Cluzel M., Joly B. Activité bactéricide in vitro des associations de triméthoprime avec différents antibiotiques. Pathol Biol (Paris) 1972 Nov;20(21):871–879. [PubMed] [Google Scholar]
  2. Greenfield S., Feingold D. S. The synergistic action of the sulfonamides and the polymyxins against Serratia marcescens. J Infect Dis. 1970 May;121(5):555–558. doi: 10.1093/infdis/121.5.555. [DOI] [PubMed] [Google Scholar]
  3. Kerry D. W., Hamilton-Miller J. M., Brumfitt W. Trimethoprim and rifampicin: in vitro activities separately and in combination. J Antimicrob Chemother. 1975 Dec;1(4):417–427. doi: 10.1093/jac/1.4.417. [DOI] [PubMed] [Google Scholar]
  4. Klastersky J., Cappel R., Daneau D. Clinical significance of in vitro synergism between antibiotics in gram-negative infections. Antimicrob Agents Chemother. 1972 Dec;2(6):470–475. doi: 10.1128/aac.2.6.470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Parsley T. L., Provonchee R. B., Glicksman C., Zinner S. H. Synergistic activity of trimethoprim and amikacin against gram-negative bacilli. Antimicrob Agents Chemother. 1977 Sep;12(3):349–352. doi: 10.1128/aac.12.3.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Rosenblatt J. E., Stewart P. R. Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against gram-negative bacilli. Antimicrob Agents Chemother. 1974 Jul;6(1):84–92. doi: 10.1128/aac.6.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES